Experts Applaud, Question President’s Pledge to End AIDS Epidemic

Donald Trump announced a plan to drastically cut HIV transmission by 2030, but some scientists and nonprofits aren’t sure the administration will follow through.

Written byCarolyn Wilke
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ABOVE: © ISTOCK.COM,
LOVE_LIFE

Last night (February 5) during his State of the Union address, President Donald Trump announced an ambitious goal to end the AIDS epidemic in the US by 2030. Responses from scientists and nonprofit groups ranged from enthusiastic to skeptical.

“Together, we will defeat AIDS in America and beyond,” Trump said in his speech. “My budget will ask Democrats and Republicans to make the needed commitment to eliminate the HIV epidemic in the United States within 10 years.”

However, Trump did not provide details on the plan, including the amount of money he would request, where it would come from, and what exactly might be done. Soon after his address, the Department of Health and Human Services released a factsheet about the plan, Science reports.

“There were high expectations that the president would use this opportunity to announce something bold on HIV in the U.S.,” Jen Kates, Kaiser ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies